Skip to main content
Clinical Trials/CTRI/2022/07/044092
CTRI/2022/07/044092
Not Yet Recruiting
Phase 2

A randomised controlled trial to evaluate the efficacy of Hinguwadi gutika and Rajahpravartini vati in the Management of Udavarta Yonivyapad W.S.R. to Primary Dysmenorrhea.

ATIONAL INSTITUTE OF AYURVEDA0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: N944- Primary dysmenorrhea
Sponsor
ATIONAL INSTITUTE OF AYURVEDA
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. PATIENTS WITH CHIEF COMPLAINT OF PAIN DURING MENSES ALONG WITH ASSOCIATED SYMPTOMS.
  • 2\. PATIENTS WHO HAVE MENSTRUAL PAIN SCORE MORE THAN GRADE I ACCORDING TO VERBAL MULTIDIMENSIONAL SCORING SYSTEM (VMSS).
  • 3\. PATIENTS WHO HAD REGULAR MENSTRAL CYCLES OF 23\-35 DAYS IN THE LAST 3 MONTHS.
  • 4\. PATIENT IN AGE GROUP OF 18 TO 30 YEARS
  • 5\. PATIENTS WITH H/O USING ANALGESICS DURING MENSES.
  • 6\. PATIENT WILLING TO GIVE VOLUNTARY INFORMED CONSENT FOR THE STUDY.

Exclusion Criteria

  • The patient suffering from any severe systemic, or autoimmune disorders, specially those who are mentioned as Asadhya vyadhi as per clinical text of Ayurveda will be excluded.
  • Subjects having organic pathology of uterus and adnexa like Fibroid uterus,carcinoma of endometrium, endometriosis etc.
  • 1having pelvic inflammatory disease or 2chronic leucorrhoea.
  • 3Patients who vaccinated for covid19 with in past three month.

Outcomes

Primary Outcomes

Not specified

Similar Trials